Optimizing ENT Prior Authorizations with Change Healthcare Clearinghouse

Navigating prior authorizations for otolaryngology (ENT) procedures and biologics requires precision. Klivira integrates seamlessly with your existing ent change healthcare clearinghouse connection to automate and accelerate this critical process.

For revenue cycle directors and prior authorization coordinators in ENT practices, managing the volume and complexity of PAs can be a significant operational burden. From advanced surgical interventions to specialized biologics, ensuring timely approvals through your clearinghouse is essential for patient care and financial health. Klivira provides a robust solution to streamline this workflow.

The Complexities of ENT Prior Authorization

Otolaryngology practices frequently encounter prior authorization requirements for a range of high-cost procedures and specialized treatments. This includes common sinus procedures like functional endoscopic sinus surgery (FESS) and balloon sinuplasty, as well as advanced interventions such as hypoglossal nerve stimulators (e.g., Inspire) and cochlear implants. The increasing use of biologics for conditions like chronic rhinosinusitis with nasal polyps further adds to the PA workload, each demanding specific clinical documentation.

Leveraging Change Healthcare for ENT Prior Authorization Workflows

As a national clearinghouse, Change Healthcare plays a pivotal role in facilitating electronic data interchange (EDI) for healthcare organizations, including prior authorization submissions. For ENT practices, this means utilizing standard HIPAA X12 transactions like the 278 for prior authorization requests, 270/271 for eligibility verification, and 276/277 for claim status. Klivira optimizes these channels, ensuring ENT-specific requests are accurately transmitted and tracked through your existing Change Healthcare clearinghouse connection.

Common ENT Procedures and Biologics Requiring Prior Authorization

  • Sinus surgeries (FESS, balloon sinuplasty) often requiring CT sinus imaging and documented conservative therapy trials.
  • Hypoglossal nerve stimulators (e.g., Inspire) and other sleep apnea-adjacent procedures, frequently necessitating polysomnography results.
  • Cochlear implants and bone-anchored hearing aids, with specific audiometry and medical necessity criteria.
  • Biologics for chronic rhinosinusitis with nasal polyps (e.g., dupilumab/Dupixent, mepolizumab/Nucala, omalizumab/Xolair), requiring adherence to step therapy protocols.
  • Septoplasty for medical necessity, requiring clear differentiation from cosmetic indications.
  • Tonsillectomy/adenoidectomy for specific pediatric and adult indications, aligned with clinical guidelines.

Klivira's Integration with Change Healthcare for ENT PA Automation

Klivira's platform integrates with your EMR and connects to the Change Healthcare clearinghouse, automating the prior authorization process for otolaryngology. Our system is designed to interpret AAO-HNS guidelines, track conservative therapy trials, and manage biologic step-therapy requirements. By intelligently compiling necessary clinical data and formatting it for X12 278 submission, Klivira reduces manual effort and accelerates approval times for critical ENT services.

Mitigating Common ENT Prior Authorization Denials

Common denial reasons in ENT include insufficient documentation of conservative care trials for sinus surgery, challenges in distinguishing cosmetic versus medically necessary septoplasty, and non-adherence to payer-mandated step therapy for biologics. Klivira proactively addresses these by ensuring comprehensive documentation is gathered and submitted. Our intelligent workflows guide your team to capture all required clinical data, significantly reducing the likelihood of denials and appeals.

Frequently asked questions

How does Klivira handle specific ENT documentation requirements?

Klivira incorporates policy logic aligned with guidelines from bodies like AAO-HNS. Our system prompts for specific documentation such as CT sinus imaging, audiometry, polysomnography, and evidence of conservative therapy trials, ensuring all necessary clinical data is captured before submission via Change Healthcare.

Can Klivira integrate with our EMR to pull ENT patient data for Change Healthcare submissions?

Yes, Klivira is designed for seamless integration with major EMR systems. This allows for automated extraction of relevant patient data, clinical notes, and order details, which are then used to populate prior authorization requests submitted electronically through your Change Healthcare clearinghouse connection.

What X12 transactions does Klivira utilize with Change Healthcare for ENT PAs?

Klivira primarily utilizes the HIPAA X12 278 transaction for prior authorization requests and responses. Additionally, we leverage X12 270/271 for eligibility and benefits verification, and X12 276/277 for status tracking, ensuring a comprehensive electronic workflow through Change Healthcare.

Does Klivira support prior authorizations for high-cost ENT biologics like Dupixent?

Absolutely. Klivira's platform includes robust capabilities for managing prior authorizations for biologics used in ENT, such as dupilumab (Dupixent), mepolizumab (Nucala), and omalizumab (Xolair). We automate the tracking and submission of step therapy requirements and other payer-specific criteria for these medications.

How does Klivira differentiate between cosmetic and medically necessary septoplasty for payers?

Klivira's policy engine guides users to provide the specific clinical documentation required by payers to establish medical necessity for septoplasty, such as objective findings of obstruction or failed medical management. This helps ensure that submissions clearly differentiate from cosmetic indications, reducing denial risks.

Related coverage

Other ent prior auth workflows

Ready to automate this workflow for this specialty?

See how Klivira automates prior authorizations for your team.

Request a demo